Naloxone for Opioid Safety: A Tool in California for Saving Lives
On January 1, 2014 the Overdose Treatment Act, became law in California. It allows lay people to possess and administer prescription naloxone to someone in urgent need who is experiencing life-threatening respiratory depression from excessive opiate use. Doctors may provide the prescription to the intended patient, a friend, family member, health care worker, or to a member of the community at large without even having met the intended recipient. Both the doctor and the lay person receive legal protection. Naloxone is a nonscheduled, non-addictive, safe, and inexpensive prescription medication which is becoming available in pharmacies throughout the state in nasal spray and injectable forms. To learn how to use it safely requires minimal instruction.
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM).Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 16.5 AMA/PRA Category 1 Credits™ for completing the Review Course.
Presented by Phillip Coffin, MD, Director of Substance Use Research at the San Francisco Department of Public Health and Eliza Wheeler, MA, MS, Drug Overdose Prevention and Education Project (DOPE), San Francisco
None of the planners or speakers have any relevant financial relationships to disclose.
- 1.00 AMA Category 1
Upon completion of this program, participants should be able to:
- Inform doctors of the new naloxone law and details of it's provisions as they apply to clinical practice.
- Spread the knowledge of the ways that naloxone can now be legally prescribed, to whom and details of the formulations/delivery systems which are now available for use by lay-persons.
- Provide doctors with practical information to build competence in determining the target populations for this medication and to help them educate patients on how to use it safely.